STOCK EXCHANGE INTIMATION 2026-2027
Shareholding Pattern
Intimation of Board Meeting-
Outcome of Board Meeting-
Financial Results-
Newspaper Publication for Results-
General Updates Under Regulation 30 of SEBI (LODR) Regulations, 2015-
- Intimation for approval received from DCGI to manufacture and market Cenobamate API & Tablets.
- Credit Rating
- Intimation for Transcript of Earnings call for Q1FY27
- Intimation for Audio Recording of Earnings Call for Q1FY27
- Intimation for Grant of Employee Stock Options under “Bajaj Healthcare Limited Employee Stock Option Plan 2024”
- Earning updates for the quarter ended 30th June 2026
- Intimation for Earnings Call for Q1FY27
- Intimation for recommendation received from SEC-CDSCO to manufacture and market Cenobamate Tablets.
- Intimation for Sale of Business Unit of the Company
- Earning updates for the quarter & year ended 31st March 2026
- Intimation of Approval received for Listing of 20,79,409 equity shares of ₹5/- each allotted pursuant to conversion of warrants issued on preferential basis
Annual Secretarial Compliance Report-
Trading Window Closure-
Compliance Certificate
Monitoring Agency Report
Integrated Filing (Financial)
Statement of Deviation & Variation
Earnings Call